Football
Barca Buy: How much is the cost for Neymar
Barcelona might have spent big to land Antoine Griezmann, but according to the latest reports, the Spanish giants have not given up on resigning Neymar.
The Blaugrana announced their acquisition of the French star on Friday, revealing that he cost the Catalan giants $135M. Immediately after this announcement, many asked what this means for the world’s most expensive player.
It’s no secret that the Brazilian wants out of PSG. The Selecao sensation hasn’t enjoyed the best of spells at Parc des Princes and yearns for a return to Camp Nou.
However, his future hinges on whether Barcelona can make a worthy bid. The Ligue 1 champions announced that they would let him go should the right offer arrive and it’s now being reported that the Spanish Primera Division champions have devised a plan to reunite Neymar with Messi and Suarez.
According to Bild (as per Marca), Barcelona are planning to offer PSG three players in exchange for the 27-year-old. This means either Coutinho or Dembele will be given up if Les Parisiens accept, with the other two being Umtiti and Semedo.
There is no mention of money and if Barcelona intend on leaving out cash, this might only make their relationship with PSG worse. Whether these terms will be accepted remains unknown. Neymar’s feelings, though, are clear.
-
Features7 days agoHow ADC leadership crisis put Atiku’s 2027 ambition at risk
-
Energy7 days agoNNPC plans 5–10% stock market listing, targets 2027 for IPO preparations
-
Business1 week agoLoveWorld Expo 2026 to showcase global innovations, emerging technologies in Lagos
-
Business4 days agoDisCos urge Minister to end blame game, apologise to Nigerians over blackouts
-
Latest7 days ago2027: No Court rulings can keep me off the ballot, Atiku insists
-
Latest1 week agoNDC faults Tinubu’s $7.7bn external loan request, raises debt concerns
-
Latest1 week ago2027: Wike declares Obi’s political wave dead, dismisses chances of presidential victory
-
Health5 days agoStudy links Pfizer COVID-19 vaccine to higher death rates than Moderna shot


